{
    "code": "01057145",
    "url": "https:\/\/info.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=01057145",
    "time": "2023-10-12 19:32:09",
    "許可證字號": "衛署藥製字第057145號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "製造許可登錄編號": "",
    "有效日期": "116\/03\/19",
    "發證\/登錄日期": "101\/03\/19",
    "許可證\/登錄種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "第一等級醫療器材原許可證字號": "",
    "第一等級醫療器材新登錄字號": "",
    "通關簽審文件編號": "DHY00105714502",
    "中文品名": "提迫黴微脂粒凍晶乾粉注射劑",
    "英文品名": "Tiposome for Injection",
    "適應症": "治療感染囊球菌腦膜炎的HIV患者。治療嚴重全⾝性及\/或深部黴菌感染。治療臟器的利時曼⽒病。在免疫不全且患有臟器的利時曼⽒病之患者使⽤Amphotericin B Liposome for Injection治療，在初期寄⽣蟲清除後仍有⾼復發率。對發燒的重度嗜中性⽩⾎球缺乏症患者可能罹患黴菌感染症之經驗療法。",
    "劑型": "247凍晶乾粉注射劑",
    "包裝": "100支以下，每⼀瓶均附有裝置好之可棄式5 micron過濾器盒裝 50毫克玻璃小瓶裝",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "05限由醫師使用",
    "管制藥品分類級別": "",
    "藥品分類": "",
    "監視期限": "",
    "主成分略述": "AMPHOTERICIN B",
    "限制項目": "01國　產 24監視期滿學名藥",
    "申請商名稱": "臺灣東洋藥品工業股份有限公司",
    "申請商地址": "台北市南港區園區街3之1號3樓",
    "主製造廠": [
        {
            "製造廠名稱": "臺灣東洋藥品工業股份有限公司六堵廠",
            "製造廠廠址": "基隆市七堵區工建西路5號",
            "製造廠公司地址": "",
            "製造廠國別": "TAIWAN",
            "製程": ""
        }
    ],
    "CCC號列": "",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "0812200102",
            "成分名稱": "AMPHOTERICIN B",
            "含量描述": "(potency)",
            "含量": "50.0000000000",
            "單位": "MG"
        }
    ],
    "仿單外盒": [
        {
            "title": "13.010571450001-103-03-14.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=01057145&Seq=002&Type=9"
        },
        {
            "title": "010571450002_標籤___20120406.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=01057145&Seq=002&Type=8"
        }
    ]
}